Therapy Insight: osteoporosis in inflammatory bowel disease—advances and retreats
Charles N Bernstein* and William D Leslie
Correspondence *University of Manitoba Inflammatory Bowel Disease Clinical and Research Centre, 804F-715 McDermot Avenue, Winnipeg, Manitoba, Canada R3E-3P4
Email cbernst@cc.umanitoba.ca
Osteoporosis is an important problem for some patients with inflammatory bowel disease (IBD). Reports of low bone mineral density (BMD) in IBD patients buoyed widespread BMD testing for osteoporosis, but data on fracture incidence have now tempered these concerns. This Review considers the authors' approach to prevention and treatment of osteoporosis in IBD patients—a controversial subject, with advocates for more or less aggressive management.
Full text of this article is available with one of the following:
- Membership of the American College of Gastroenterology. If already a member, please login.
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please log in for immediate access.
- 7 day single article pass for US$32 In order to purchase this article you must be a registered user. Please register or log in.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
RESEARCH
Bone loss and the aromatase inhibitorsBritish Journal of Cancer Original Article
See all 30 matches for Research